Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

Rosenstock Julio and Perkovic Vlado and Johansen Odd Erik and Cooper Mark E. and Kahn Steven E. and Kollaborációs szervezet: CARMELINA Investigators and Mihály Emese and Keltai Katalin and Baló Tímea and Somogyi Anikó and Nagy Géza and Tabák Ádám and Ferencz Viktória and Domján Beatrix Annamária and Tänczer Tímea and Bajnok László Zoltán and Szujó Szabina and Nemes Orsolya and Mezősi Emese and Bódis Beáta and Márton Zsolt and Takács Róbert and Ábrahám György and Fehértemplomi Katalin and et al. (kollab. közrem.): Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 321 (1). pp. 69-79. ISSN 0098-7484 (2019)

[thumbnail of Rosenstock.pdf] Text
Rosenstock.pdf - Published Version

Download (411kB)
Item Type: Journal Article
Szerzők száma: 71
Journal or Publication Title: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Date: 2019
Volume: 321
Number: 1
Page Range: pp. 69-79
ISSN: 0098-7484
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 30470479
DOI azonosító: https://doi.org/10.1001/jama.2018.18269
Date Deposited: 2023. May. 19. 09:52
Last Modified: 2023. May. 19. 09:52
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/27237
Web of Science® Times Cited: 642 View citing articles in Web of Science®

Actions (login required)

View Item View Item